MAP kinase P38 binding compounds
US10293024B2 · kind B2 · utility
0Cited by
2References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 15, 2014 |
| Grant date | May 21, 2019 |
| Priority date | — |
| Expiry date | Aug 15, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/91205
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound comprising the amino acid sequence HKSRALLIFQKIMWLRRQ (SEQ ID No: 1) or comprising a part of said amino acid sequence of 7 or more amino acids, or comprising a variant of said amino acid sequence or said part thereof in which from 1 to 5 amino acids have been altered, wherein the compound binds to MAP kinase p38α. The compounds are useful in binding to and inhibiting MAP kinase p38α, and are useful as research tools, in drug discovery, medicine, particularly for treating inflammatory conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.